Summary of Bruker Corporation (NASDAQ:BRKR) Ratings as of Jan 14, 2019

Bruker Corporation (NASDAQ:BRKR) Corporate Logo
During Q3 2018 the big money sentiment decreased to 0.71. That’s change of 0.33, from 2018Q2’s 1.04. 21 investors sold all, 82 reduced holdings as Bruker Corporation ratio dived. 50 increased holdings while 23 funds amassed holdings. Funds hold 98.95 million shares thus 0.78% less from 2018Q2’s 99.72 million shares.
Tdam Usa holds 51,232 shs or 0.1% of its capital. 27,161 are held by Lpl Fincl Limited Liability. Pnc Fin Services Gp owns 546 shs. Wells Fargo And Mn has 0.01% invested in Bruker Corporation (NASDAQ:BRKR) for 762,213 shs. Qs Investors Ltd Limited Liability Company owns 136,274 shs for 0.04% of their capital. California Public Employees Retirement accumulated 0.01% or 202,450 shs. Northern Trust reported 0% of its capital in Bruker Corporation (NASDAQ:BRKR). Hanseatic Svcs invested in 1,113 shs. Principal Financial Gru reported 14,483 shs. Renaissance Limited Liability Corporation accumulated 0% or 91,610 shs. Thompson Rubinstein Invest Or invested 1.45% of its capital in Bruker Corporation (NASDAQ:BRKR). Acadian Asset Mngmt Ltd Liability Corp owns 4.66M shs or 0.64% of their US capital. Brinker Inc accumulated 19,275 shs. Earnest Ptnrs Ltd Co holds 24 shs. State Common Retirement Fund owns 452,207 shs or 0.02% of their US capital.

Bruker Corporation (NASDAQ:BRKR) Ratings Coverage

A total of 2 analysts rate Bruker (NASDAQ:BRKR) as follows: 1 “Buy”, 0 “Hold” and 1 “Sell”. Тherefore 50% are bullish. (NASDAQ:BRKR) has 3 ratings reports on Jan 14, 2019 according to StockzIntelligence. On Friday, August 3 the stock of Bruker Corporation (NASDAQ:BRKR) earned “Equal-Weight” rating by Morgan Stanley. In Thursday, September 20 report Morgan Stanley downgraded the stock to “Underweight” rating. Listed here are Bruker Corporation (NASDAQ:BRKR) PTs and latest ratings.

03/01/2019 Broker: Needham Rating: Strong Buy New Target: $39 Initiates Coverage On
20/09/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Underweight Old Target: $31 New Target: $32 Downgrade
03/08/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $29 New Target: $31 Maintain

BRKR is touching $33.6 during the last trading session, after increased 0.69%.Bruker Corporation has volume of 717,727 shares. Since January 14, 2018 BRKR has declined 8.69% and is downtrending. BRKR underperformed by 8.69% the S&P 500.

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide.The company has $5.26 billion market cap. The firm operates through two divisions, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies.53.5 is the P/E ratio. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions.

For more Bruker Corporation (NASDAQ:BRKR) news brought out briefly go to:,,, or The titles are as follows: “Tap 4 Best-Performing Liquid Bets to Boost Portfolio Returns – Nasdaq” brought out on January 04, 2019, “Bruker Comments on Block Trade Transaction – PRNewswire” on December 20, 2018, “Bruker completes the acquisition of Alicona Imaging – Seeking Alpha” with a publish date: December 18, 2018, “Bruker Completes the Acquisition of Alicona Imaging GmbH – PRNewswire” and the last “Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence – Nasdaq” with publication date: January 03, 2019.

Bruker Corporation (NASDAQ:BRKR) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.